SG11201807478QA - Methods and compositions for increased double stranded rna production - Google Patents
Methods and compositions for increased double stranded rna productionInfo
- Publication number
- SG11201807478QA SG11201807478QA SG11201807478QA SG11201807478QA SG11201807478QA SG 11201807478Q A SG11201807478Q A SG 11201807478QA SG 11201807478Q A SG11201807478Q A SG 11201807478QA SG 11201807478Q A SG11201807478Q A SG 11201807478QA SG 11201807478Q A SG11201807478Q A SG 11201807478QA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- dsrna
- suite
- louis
- rule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/50—Biochemical production, i.e. in a transformed host cell
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18111—Leviviridae
- C12N2795/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662308381P | 2016-03-15 | 2016-03-15 | |
| PCT/US2017/021661 WO2017160600A1 (en) | 2016-03-15 | 2017-03-09 | Methods and compositions for increased double stranded rna production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201807478QA true SG11201807478QA (en) | 2018-09-27 |
Family
ID=59851196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201807478QA SG11201807478QA (en) | 2016-03-15 | 2017-03-09 | Methods and compositions for increased double stranded rna production |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10704045B2 (zh) |
| EP (1) | EP3429336A4 (zh) |
| JP (2) | JP7140386B2 (zh) |
| CN (2) | CN115927299A (zh) |
| AU (1) | AU2017233862B2 (zh) |
| BR (1) | BR112018068144A2 (zh) |
| CA (1) | CA3016899C (zh) |
| IL (1) | IL261516A (zh) |
| MX (2) | MX2018011170A (zh) |
| SG (1) | SG11201807478QA (zh) |
| WO (1) | WO2017160600A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3294276A4 (en) * | 2015-05-12 | 2018-10-31 | Apse, Llc | In vivo production of long double stranded rna utilizing vlps |
| JP7140386B2 (ja) | 2016-03-15 | 2022-09-21 | アプス， インコーポレイテッド | 増加した二本鎖ｒｎａ産生のための方法及び組成物 |
| EP3601583A1 (en) * | 2017-03-28 | 2020-02-05 | Ajinomoto Co., Inc. | Method for producing rna |
| US20220304315A1 (en) * | 2019-05-30 | 2022-09-29 | Rnaissance Ag Llc | Methods and compositions for microbial delivery of double stranded rna |
| AU2020283038A1 (en) | 2019-05-30 | 2022-01-06 | RNAissance Ag, LLC | Improved methods and compositions for increased double stranded RNA production |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020164585A1 (en) * | 1998-01-16 | 2002-11-07 | Sean Chapman | Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids |
| WO2006045591A2 (en) | 2004-10-25 | 2006-05-04 | Devgen N.V. | Method and constructs for delivering double stranded rna to pest organisms |
| ATE515566T1 (de) * | 2005-05-26 | 2011-07-15 | Cytos Biotechnology Ag | Skalierbares fermentationsverfahren |
| US8324149B2 (en) * | 2008-11-18 | 2012-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Encapsidation of heterologous entities into virus-like particles |
| AR089440A1 (es) | 2011-12-21 | 2014-08-20 | Apse Llc | Procesos que emplean particulas similares a virus (psv) con capsides resistentes a hidrolasas |
| GB201202119D0 (en) * | 2012-02-08 | 2012-03-21 | Univ Swansea | Pest and pathogen control |
| EP3434777B1 (en) * | 2013-03-15 | 2020-09-23 | Monsanto Technology LLC | Compositions and methods for the production and delivery of rna |
| CA2907198C (en) * | 2013-03-15 | 2019-12-10 | The General Hospital Corporation | Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing |
| HUE053033T2 (hu) | 2013-06-19 | 2021-06-28 | Apse Llc | Hidrolázoknak ellenálló kapszidokat alkalmazó készítmények és eljárások |
| US9932563B2 (en) * | 2013-09-11 | 2018-04-03 | Georgia Tech Research Corporation | Compositions and methods for inhibiting gene expressions |
| US10329560B2 (en) | 2013-09-23 | 2019-06-25 | Georgia Tech Research Corporation | Targeting non-coding RNA for RNA interference |
| US9902965B2 (en) | 2013-11-14 | 2018-02-27 | Scarab Genomics, Llc | Bacteria with improved metabolic capacity |
| EP3294276A4 (en) | 2015-05-12 | 2018-10-31 | Apse, Llc | In vivo production of long double stranded rna utilizing vlps |
| JP7140386B2 (ja) | 2016-03-15 | 2022-09-21 | アプス， インコーポレイテッド | 増加した二本鎖ｒｎａ産生のための方法及び組成物 |
-
2017
- 2017-03-09 JP JP2018548933A patent/JP7140386B2/ja active Active
- 2017-03-09 EP EP17767194.8A patent/EP3429336A4/en active Pending
- 2017-03-09 SG SG11201807478QA patent/SG11201807478QA/en unknown
- 2017-03-09 CA CA3016899A patent/CA3016899C/en active Active
- 2017-03-09 BR BR112018068144A patent/BR112018068144A2/pt not_active Application Discontinuation
- 2017-03-09 MX MX2018011170A patent/MX2018011170A/es unknown
- 2017-03-09 WO PCT/US2017/021661 patent/WO2017160600A1/en active Application Filing
- 2017-03-09 CN CN202210337486.2A patent/CN115927299A/zh active Pending
- 2017-03-09 AU AU2017233862A patent/AU2017233862B2/en active Active
- 2017-03-09 US US16/084,545 patent/US10704045B2/en active Active
- 2017-03-09 CN CN201780018422.3A patent/CN109196102B/zh active Active
-
2018
- 2018-09-02 IL IL261516A patent/IL261516A/en unknown
- 2018-09-14 MX MX2020013746A patent/MX2020013746A/es unknown
-
2020
- 2020-07-07 US US16/922,948 patent/US11718851B2/en active Active
-
2022
- 2022-04-15 JP JP2022067530A patent/JP2022087312A/ja active Pending
-
2023
- 2023-06-27 US US18/342,407 patent/US20230416744A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220145294A1 (en) | 2022-05-12 |
| US10704045B2 (en) | 2020-07-07 |
| JP7140386B2 (ja) | 2022-09-21 |
| MX2020013746A (es) | 2021-03-02 |
| CA3016899A1 (en) | 2017-09-21 |
| US20190093108A1 (en) | 2019-03-28 |
| CA3016899C (en) | 2023-09-19 |
| EP3429336A1 (en) | 2019-01-23 |
| JP2019508060A (ja) | 2019-03-28 |
| US11718851B2 (en) | 2023-08-08 |
| US20230416744A1 (en) | 2023-12-28 |
| BR112018068144A2 (pt) | 2019-02-12 |
| AU2017233862B2 (en) | 2023-04-13 |
| CN109196102B (zh) | 2022-04-26 |
| MX2018011170A (es) | 2019-05-16 |
| WO2017160600A1 (en) | 2017-09-21 |
| EP3429336A4 (en) | 2019-10-30 |
| AU2017233862A1 (en) | 2018-10-04 |
| IL261516A (en) | 2018-10-31 |
| CN115927299A (zh) | 2023-04-07 |
| CN109196102A (zh) | 2019-01-11 |
| JP2022087312A (ja) | 2022-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201909344SA (en) | Anti-lag3 antibodies | |
| SG11201807478QA (en) | Methods and compositions for increased double stranded rna production | |
| SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
| SG11201908813QA (en) | Anti-sirp alpha antibodies | |
| SG11201807426WA (en) | Immunomodulators | |
| SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
| SG11201903857UA (en) | Antibodies to pd-1 and uses thereof | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201909022PA (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
| SG11201806496SA (en) | Antigen binding proteins that bind pd-l1 | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201810420YA (en) | Antibodies to alpha-synuclein and uses thereof | |
| SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
| SG11201809830WA (en) | Selective reduction of cysteine-engineered antibodies | |
| SG11201804890TA (en) | Bipyrazolyl derivatives useful for the treatment of autoimmune diseases | |
| SG11201908127WA (en) | Method for producing multispecific antibodies | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201809497RA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201907364WA (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| SG11201806432PA (en) | Methods for assessing risk of developing colorectal cancer | |
| SG11201907208XA (en) | Radiolabeled anti-lag3 antibodies for immuno-pet imaging | |
| SG11201908825TA (en) | Stable multispecific antibodies | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer |